Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Dallas, Texas 75235


To determine whether using a long-acting insulin analog at the time of diagnosis, instead of intermediate-acting insulin, affects the rate of loss of the body's ability to make insulin in children with newly diagnosed type 1 diabetes.


Inclusion Criteria: - Newly diagnosed type 1 diabetes within 1 week of diagnosis - Age 6 - 18 years - Care provided at Children's Medical Center, Dallas Exclusion Criteria: - Actual treatment with oral drugs influencing beta cell function or blood glucose levels (e.g. oral hypoglycemic agents) - Actual treatment with drugs influencing insulin sensitivity (e.g. Metformin, or systemic steroids) - Significant concomitant disease likely to interfere with glucose metabolism (children with active bacterial infections at the time of diagnosis must be cured prior to entry) - Expected poor compliance - Pregnancy - Any other condition that by the judgement of the investigator may be potentially harmful to the patients



Primary Contact:

Principal Investigator
Soumya Adhikari, MD
University of Texas Southwestern Medical Center

Backup Contact:


Location Contact:

Dallas, Texas 75235
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.